Clofenetamine (INN ), also known as phenoxethamine or as Keithon, is a drug described as a tranquilizer, antihistamine, anticholinergic, and antiparkinsonian agent.[1][2] It is a derivative of diphenhydramine and is closely structurally related to mephenhydramine, chlorphenoxamine, and embramine, among other drugs.[2] Clofenetamine was discovered by Searle in the 1940s and was first described in the literature by 1956.[3][1]
Clinical data | |
---|---|
Other names | Phenoxethamine; Keithon |
Drug class | Tranquilizer; Antihistamine; Anticholinergic; Antiparkinsonian agent |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H26ClNO |
Molar mass | 331.88 g·mol−1 |
3D model (JSmol) | |
| |
|
References
edit- ^ a b Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 295. ISBN 978-1-4757-2085-3. Retrieved 17 October 2024.
- ^ a b Ariëns EJ (2013). Drug Design: Medicinal Chemistry: A Series of Monographs. Vol. 6. Academic Press. pp. 12–13. ISBN 978-1-4832-1608-9. Retrieved 17 October 2024.12-13&rft.pub=Academic Press&rft.date=2013&rft.isbn=978-1-4832-1608-9&rft.aulast=Ariëns&rft.aufirst=EJ&rft_id=https://books.google.com/books?id=PQwlBQAAQBAJ&pg=PA12&rfr_id=info:sid/en.wikipedia.org:Clofenetamine" class="Z3988">
- ^ "CLOFENETAMINE". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS), U.S National Institutes of Health. Retrieved 17 October 2024.
Clofenetamine is a haloxanthine antihistamine compound discovered by Searle & Co in the 1940s.